Dupla, Janejane C.
HRN: 27-08-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
CEFUROXIME 1.5GM (VIAL)
05/05/2025
05/06/2025
IV
1.5 Grams
ON CALL TO OR THEN Q 8 HRS
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes